Chris Bunka

Chris was the former CEO of Lexaria and has been Chairman of the Board since 2006 and was primarily responsible for the corporate pivot from older business activities to bioscience.

Chris is a serial entrepreneur and has been involved in several private and public companies since the late 1980’s. He was well known for more than a decade as a part-time business commentator in print and radio, as well as an author. He has extensive experience in the capital markets, corporate governance, project acquisition and corporate finance. He is a named inventor on some of Lexaria’s pending patents.